The FDA Boss on the Agency’s MAHA Makeover
The Journal.
00:00
FDA's Response to 7-OH: A New Opioid Concern
This chapter explores the FDA's recent actions regarding 7-OH, a potent compound from the Kratom plant, highlighting its opioid-like risks and availability. The discussion underscores the urgency for public awareness and calls for a more proactive and responsive FDA in addressing the ongoing opioid crisis.
Transcript
Play full episode
